WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 2998

Legislative bill overview

SB 2998 relates to medical cannabis policy in Hawaii, though the specific provisions are not detailed in the action history provided. Based on the bill's referral to the Health and Human Services/Labor and Business Tax committee and Judiciary/Consumer Protection and Native Hawaiian Rights committee, it likely addresses either regulatory, patient access, business licensing, or legal framework aspects of Hawaii's existing medical cannabis program.

Why is this important

Hawaii has operated a medical cannabis program since 2000, and ongoing legislative adjustments typically address implementation gaps, regulatory updates, or patient access issues. Changes to medical cannabis policy directly affect patient treatment options, business licensing procedures, tax revenue, and law enforcement priorities in the state.

Potential points of contention

  • Program access vs. regulatory oversight: Balancing patient access with maintaining adequate regulatory controls and safety standards
  • Social equity and licensing: Questions about whether the program sufficiently addresses historical inequities or prioritizes certain applicant types in licensing decisions
  • Tax and revenue implications: Disputes over tax rates, fee structures, or revenue allocation between general funds and program administration

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.